BackNanobac Pharmaceuticals Overview

Nanobac Pharmaceuticals Research & Development

Research & Development expenses for NNBP.

Quarterly R&D Expenses

$226409.00
73.43% YoY

As of Dec 31, 2007

Annual R&D Expenses (TTM)

$1.15M
42.38% YoY

Trailing 12 months ending Dec 31, 2007

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)